Skip to main content
SpringerLink
Log in

TRH: Pathophysiologic and clinical implications

  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

Thyrotropin releasing hormone is thought to be a tonic stimulator of the pituitary TSH secretion regulating the setpoint of the thyrotrophs to the suppressive effect of thyroid hormones. The peptide stimulates the release of normal and elevated prolactin. ACTH and GH may increase in response to exogenous TRH in pituitary ACTH and GH hypersecretion syndromes and in some extrapituitary diseases.

The pathophysiological implications of extrahypothalamic TRH in humans are essentially unknown.

The TSH response to TRH is nowadays widely used as a diganostic amplifier in thyroid diseases being suppressed in borderline and overt hyperthyroid states and increased in primary thyroid failure. In hypothyroid states of hypothalamic origin, TSH increases in response to exogenous TRH often with a delayed and/or exaggerated time course.

But in patients with pituitary tumors and suprasellar extension TSH may also respond to TRH despite secondary hypothyroidism. This TSH increase may indicate a suprasellar cause for the secondary hypothyroidism, probably due to portal vessel occlusion. The TSH released in these cases is shown to be biologically inactive.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ahuja, S., Baumgarten, S., Oeff, K., Repetitive intravenous TRH-stimulations at short intervals in euthyroid and hypothyroid subjects. Acta Endocrinol. (Kbh)93 (1980), 20–24.

    Google Scholar 

  2. Arafah, B. M., Brodkey, J. S., Manni, A., Velasco, M. E., Kaufmann, B., Pearson, O. H., Recovery of pituitary function following surgical removal of large nonfunctioning pituitary adenomas. Clinical Endocrinol.17 (1982), 213–222.

    Google Scholar 

  3. Barnett, A. H., Donald, R. A., Espiner, E. A., High concentrations of thyroid stimulating hormone in untreated glucocorticoid deficiency: Indication of primary hypothyroidism? Brit. med. J.285 (1982), 172–173.

    Google Scholar 

  4. Benkert, O., Horn, K., Pickardt, C. R., Schmid, D., Sexual impotence: Studies on the hypothalamic pituitary thyroid axis and the effect of oral thyrotropin releasing factor. Arch. Sex. Behav.5 (1976), 275–281.

    Google Scholar 

  5. Burrow, G. N., May, P. B., Spaulding, S. W., Donabedian, R. K., TRH and dopamine interactions affecting pituitary hormone secretion. J. Clin. Endocrinol. Metab.45 (1977), 65–72.

    PubMed  Google Scholar 

  6. Carr, C., Gomez-Pan, A., Weightman, D. R., Roy, V. C. M., Hall, R., Besser, G. M., Thorner, M. O., McNeilly, A. S., Schally, A. V., Kastin, A. J., Coy, D. H., Growth hormone release inhibiting hormone: Action on thyrotropin and prolactin secretion after thyrotrophin releasing hormons. Brit. med. J.3 (1975), 67–69.

    PubMed  Google Scholar 

  7. Ceda, G. P., Speroni, G., Dall'Aglio, E., Valenti, G., Butturini, U., Nonspecific growth hormone responses to thyrotrophin releasing hormone in insulin-dependent diabetes: Sex- and agerelated pituitary responsiveness. J. Clin. Endocrinol. Metab.55 (1982), 170–174.

    PubMed  Google Scholar 

  8. Chen, H. J., Meites, J., Effects of biogenic amines and TRH on release of prolactin and TSH in the rat. Endocrinology96 (1975), 10–22.

    PubMed  Google Scholar 

  9. Clark, A. J. L., Mashiter, K., Goolden, A. W., Joplin, G. F., Hyperprolactinemia after external irradiation for acromegaly. Clin. Endocrinol.17 (1982), 291–295.

    Google Scholar 

  10. Cobb, W. E., Reichlin, S., Jackson, I. M. D., Growth hormone secretory status is a determinant of the thyrotropin response to thyrotropin releasing hormone in euthyroid patients with hypothalamic pituitary diseases. J. Clin. Endocrinol. Metab.52 (1981), 324–329.

    PubMed  Google Scholar 

  11. Cooper, D. S., Klibanski, A., Ridgway, E. C., Dopaminergic modulation of TSH and its subunits: In vivo and in vitro studies. Clinical Endocrinology18 (1983), 265–275.

    PubMed  Google Scholar 

  12. Dolva, L. Ø., Hanssen, K. F., Berstad, A., Frey, H. M. M., Thyrotrophin releasing hormone inhibits the pentagastrin stimulated gastric secretion in man, a dose response study. Clinical Endocrinology10 (1979), 281–286.

    PubMed  Google Scholar 

  13. Dolva, L. Ø., Hanssen, K. F., Flaten, O., Hanssen, L. E., von Schenck, H., The effect of thyrotrophin-releasing hormone (TRH) on pancreatic hormone secretion in normal subjects. Acta Endocrinol. (Kbh)102 (1983), 224–230.

    Google Scholar 

  14. Dolva, L. Ø., Hanssen, K. F., Aadland, E., Sand, T., Thyrotropin-releasing hormone immunoreactivity in the gastrointestinal tract of man. J. Clin. Endocrinol. Metab.56 (1983), 524–529.

    PubMed  Google Scholar 

  15. Engel, W. K., Siddique, T., Nicoloff, J. T., Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropinreleasing hormone. LancetI (1983), 73–75.

    Google Scholar 

  16. Enjalbert, A., Epelbaum, J., Arancibia, S., Tapia-Arancibia, L., Bluet-Pajot, M. Th., Kordon, C., Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro. Endocrinology111 (1982), 42–47.

    PubMed  Google Scholar 

  17. Evain-Brion, D., Garnier, P., Schimpff, R. M., Chaussain, J. L., Job, J. C., Growth hormone response to thyrotropin-releasing hormone and oral glucose-loading test in tall children and adolescents. J. Clin. Endocrinol. Metab.56 (1983), 429–432.

    PubMed  Google Scholar 

  18. Faden, A. I., Jacobs, T. P., Holaday, J. W., Thyrotropinreleasing hormone improves neurologic recovery after spinal trauma in cats. N. Engl. J. Med.305 (1981), 1063–1067.

    PubMed  Google Scholar 

  19. Faglia, G., Beck-Peccoz, P., Ambrosi, B., Ferrari, C., Neri, V., Prolonged and exaggerated elevations in plasma thyrotropin (HTSH) after thyrotropin releasing factor (TRF) in patients with pituitary tumors. J. Clin. Endocrinol. Metab.33 (1971), 999–1002.

    PubMed  Google Scholar 

  20. Faglia, G., Beck-Peccoz, P., Ferrari, C., Ambrosi, B., Spada, A., Travaglini, P., Enhanced plasma thyrotrophin response to thyrotrophin releasing hormone following oestradiol administration in man. Clinical Endocrinology2 (1973), 207–210.

    PubMed  Google Scholar 

  21. Faglia, G., Ferrari, C., Beck-Peccoz, P., Spada, A., Travaglini, P., Ambrosi, B., Reduced plasma thyrotropin response to thyrotropin releasing hormone after dexamethasone administration in normal subjects. Horm. Metab. Res.5 (1973), 289–292.

    PubMed  Google Scholar 

  22. Faglia, G., Ferrari, C., Paracchi, A., Spada, A., Beck-Peccoz, P., Triiodothyronine response to thyrotrophin releasing hormone in patients with hypothalamic-pituitary disorders. Clinical Endocrinology4 (1975), 585–590.

    PubMed  Google Scholar 

  23. Faglia, C., Bitensky, L., Pinchera, A., Ferrari, C., Paracchi, A., Beck-Peccoz, P., Ambrosi, B., Spada, A., Thyrotropin secretion in patients with central hypothyroidism: Evidence for reduced biological activity of immunoreactive thyrotropin. J. Clin. Endocrinol. Metab.48 (1979), 989–998.

    PubMed  Google Scholar 

  24. Faglia, G., Beck-Peccoz, P., Ballabio, M., Nava, C., Excess of βsubunit of thyrotropin (TSH) in patients with idiopathic central hypothyroidism due to the secretion of TSH with reduced biological activity. J. Clin. Endocrinol. Metab.56 (1983), 908–914.

    PubMed  Google Scholar 

  25. Feek, C. M., Sawers, J. S. A., Brown, N. S., Seth, J., Irvine, W. J., Toft, A. D., Influence of the thyroid status on dopaminergic inhibition of thyrotropin and prolactin secretion: Evidence of an additional feedback mechanism in the control of thyroid hormone secretion. J. Clin. Endocrinol. Metab.51 (1980), 585–589.

    PubMed  Google Scholar 

  26. Flückiger, E., del Pozo, E., von Werder, K., Prolactin, physiology, pharmacology and clinical findings. Monographs in Endocrinology23. Berlin-Heidelberg-New York: Springer. 1982

    Google Scholar 

  27. Foord, St. M., Peters, J. R., Dieguez, C., Scanlon, M. F., Hall, R., Dopamine receptors on intact anterior pituitary cells in culture: Functional association with the inhibition of prolactin and thyrotropin. Endocrinology112 (1983), 1567–1577.

    PubMed  Google Scholar 

  28. Fraser, H. M., McNeilly, A. S., Effect of chronic immunoneutralization of thyrotropin releasing hormone on the hypothalamic pituitary thyroid axis, prolactin and reproductive function in the ewe. Endocrinology111 (1982), 1964–1973.

    PubMed  Google Scholar 

  29. Guignier, F., Pelletier, J. L., Touzery, C., Gailliard, P., Thyrotropin-releasing hormone radioimmunoassay in human serum and its application in thyroidal pathology. Eur. J. Nucl. Med.6 (1981), 73–78.

    PubMed  Google Scholar 

  30. Habermann, J., Leisner, B., Witte, A., Pickard, C. R., Scriba, P. C., Iodine contamination as a cause of hyperthyroidism or lack of TSH response to TRH stimulation (results based on a screening investigation). J. Endocrinol. Invest.5 (1982), 153–156.

    PubMed  Google Scholar 

  31. Hall, R., Ormston, B. J., Besser, G. M., Cryer, R. J., McKendrick, M., The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. LancetI (1972), 754–763.

    Google Scholar 

  32. Hefco, E., Krulich, L., Aschenbrenner, J. E., Effect of hypothalamic deafferentiation on the secretion of thyrotropin during thyroid blockade and exposure to cold in the rat. Endocrinology97 (1975), 1234–1240.

    PubMed  Google Scholar 

  33. Hiramatsu, K., Hashizume, K., Aizawa, T., Ichikawa, K., Yamada, T., Thyrotropin secretion in patients with hyperparathyroidism or hypoparathyroidism: Effect of serum calcium on thyrotropin release. J. Clin. Endocrinol. Metab.56 (1983), 623–626.

    PubMed  Google Scholar 

  34. Horn, K., Erhardt, F., Fahlbusch, F., Pickardt, C. R., von Werder, K., Scriba, P. C., Recurrent goiter, hyperthyroidism, galactorrhea and amenorrhea due to a thyrotropin and prolactin-producing pituitary tumor. J. Clin. Endocrinol. Metab.43 (1976), 137–143.

    PubMed  Google Scholar 

  35. Hugues, J.-N., Burger. A. G., Grouselle, D., Voirol, M. J., Chabert, P., Modigliani, E., Sebaoun, J., Evidence of a thyrotropin-releasing hormone dependent increase in plasma thyrotropin during refeeding of starved rats. Endocrinology112 (1983), 715–719.

    PubMed  Google Scholar 

  36. Jackson, J. M. D., Thyrotropin releasing hormone (TRH): Distribution in mammalian species and its functional significance. In: Thyrotropin Releasing Hormone (Griffiths, E. C., Benett, G. W., eds.), PP.3–18. New York: Raven Press.

  37. Johannson, O., Hökfelt, T., Jeffcoate, S. L., White, N., Spindel, E., Light and electron microscopic immunohistochemical studies on TRH in the central nervous system of the rat. In: Thyrotropin Releasing Hormone (Griffiths, E. C., Benett, G. W., eds.), pp. 19–32. New York: Raven Press.

  38. Klindt, J., Davis, S. L., Ohlson, D. L., Plasma concentration of thyrotropin-releasing hormone, thyrotropin, prolactin and growth hormone during five-day osmotic pump infusion of thyrotropin-releasing hormone. Endocrinology104 (1979), 45–79.

    PubMed  Google Scholar 

  39. Koch, Y., Goldhaber, G., Fireman, I., Zor, U., Shani, J., Tal, E., Suppression of prolactin and thyrotropin secretion in the rat by antiserum to thyrotropin-releasing hormone. Endocrinology100 (1977), 1476–1478.

    PubMed  Google Scholar 

  40. Köbberling, J., Darragh, A., del Pozo, E., Chronic dopamine receptor stimulation using bromocriptine: Failure to modify thyroid function. Clinical Endocrinology11 (1979), 367–370.

    PubMed  Google Scholar 

  41. Kuku, S. F., Child, D. F., Nader, S., Fraser, T. R., Thyrotrophin and prolactin responsiveness to thyrotrophin releasing hormone in Cushing's disease. Clinical Endocrinology4 (1975), 437–442.

    PubMed  Google Scholar 

  42. Labrie, F., Drouin, J., Ferlang, L., Lagacé, L., Beaulieu, M., de Léan, A., Kelly, P. A., Caron, M. G., Raymoud, V., Mechanism of action of hypothalamic hormones in the anterior pituitary gland and specific modulation of their activity by sex steroids and thyroid hormones. In: Rec. Progr. Horm. Res.34 (1978), 25–93.

    PubMed  Google Scholar 

  43. Jacobs, L. S., Snyder, P. J., Utiger, R. D., Daughaday, W. H., Prolactin response to thyrotropin-releasing hormone in normal subjects. J. Clin. Endocrinol. Metab.36 (1973), 1069–1070.

    PubMed  Google Scholar 

  44. Lechan, R. M., Jackson, I. M. D., Immunohistochemical localization of thyrotropin releasing hormone in the rat hypothalamus and pituitary. Endocrinology11 (1982), 55–65.

    Google Scholar 

  45. L'Hermite, M., Vanhaelst, L., Copinschi, G., Leclercq, R., Goldstein, L., Bruno, O. D., Robyn, C., Prolactin release after injection of thyrotrophin releasing hormone in man. LancetI (1972), 763–764.

    Google Scholar 

  46. Mallik, T. K., Wilber, J. F., Pegues, J., Measurements of thyrotropin-releasing hormone like material in human peripheral blood by affinity chromatography and radioimmunoassay. J. Clin. Endocrinol. Metab.54 (1982), 1194–1198.

    PubMed  Google Scholar 

  47. Martin, J. B., Boshans, R., Reichlin, S., Feedback regulation of TSH-secretion in rats with hypothalamic lesions. Endocrinology87 (1970), 1032–1040.

    PubMed  Google Scholar 

  48. Massara, F., Camanni, F., Amoroso, A., Molinatti, G. M., Müller, E. E., Increased thyrotrophin and prolactin secretion induced by domperidone in hypothyroid subjects. Acta Endocrinol. (Kbh)97 (1981) 48–53.

    Google Scholar 

  49. Maurer, R. A., Thyroid hormone specifically inhibits prolactin synthesis and decreases prolactin messenger ribonucleic acid levels in cultured pituitary cells. Endocrinology110 (1982), 1507–1520.

    PubMed  Google Scholar 

  50. Mitsuma, T., Hirooka, Y., Nihei, N., Radioimmunoassay of thyrotrophin releasing hormone in human serum and its clinical application. Acta Endocrinol. (Kbh)83 (1976), 225–235.

    Google Scholar 

  51. Mongioi, A., Aliffi, A., Vicari, E., Coniglione, F., Scapagnini, U., D'Agata, R., Down-regulation of prolactin secretion in men during continuous thyrotropin-releasing hormone infusion: Evidence of induction of pituitary desensitization by continuous TRH administration. J. Clin. Endocrinol. Metab.56 (1983), 904–907.

    PubMed  Google Scholar 

  52. Montoya, E., Seidel, M. J., Wilber, J. F., Thyrotropin-releasing hormone secretory physiology: Studies by radioimmunoassay and affinity chromatography. Endocrinology96 (1975), 1413–1418.

    PubMed  Google Scholar 

  53. Nillson, K. O., Thorell, J. I., Hökfelt, D., The effect of thyrotrophin releasing hormone on the release of thyrotrophin and other pituitary hormones in man under basal conditions and following adrenergic blocking agents. Acta Endocrinol. (Kbh)76 (1974), 24–34.

    Google Scholar 

  54. Otsuki, M., Dakoda, M., Baba, S., Influence of glucocorticoids on TRH-induced TSH-response in man. J. Clin. Endocrinol. Metab.36 (1973), 95–102.

    PubMed  Google Scholar 

  55. Petersen, V. B., McGregor, A. M., Belchetz, P. E., Elkeles, R. S., Hall, R., The secretion of thyrotrophin with impaired biological activity in patients with hypothalamic-pituitary disease. Clinical Endocrinology8 (1978), 397–402.

    PubMed  Google Scholar 

  56. Pickardt, C. R., Geiger, W., Fahlbusch, R., Scriba, P. C., Stimulation der TSH-Sekretion durch TRF-Belastung bei hypothalamischen und hypophysären Krankheitsbildern. Klin. Wschr.50 (1972), 42–52.

    PubMed  Google Scholar 

  57. Pickardt, C. R., Erhardt, F., Fahlbusch, R., Scriba, P. C., Portal vessel occlusion: A cause for pituitary insufficiency in patients with pituitary tumors? Europ. J. Clin. Invest.3 (1973), 262.

    Google Scholar 

  58. Pickardt, C. R., Erhardt, F., Fahlbusch, R., Grüner, J., Scriba, P. C., The diagnostic significance of the stimulation of TSH secretion by thyrotropin releasing hormone (TRH) administration in diseases of the hypothalamus and pituitary. Excerpta Med. (Amsterdam) ICS306 (1973), 105–107.

    Google Scholar 

  59. Pickardt, C. R., Erhardt, F., Grüner, J., Heinze, H. G., Horn, K., Scriba, P. C., Stimulierbarkeit der TSH-Sekretion durch TRH bei autonomen Adenomen der Schilddrüse. Dtsch. med. Wschr.98 (1973), 152–157.

    PubMed  Google Scholar 

  60. Pickardt, C. R., Theisen, F., Witte, A., Leisner, B., Theisen, K., Jahrmärker, H., Effects of long-term treatment with amiodarone on thyroid function and thyroidal iodine concentration. In: New Aspects in the Medical Treatment of Tachyarrhythmias-Role of Amiodarone (Breithardt, G., Loogen, F., eds.), pp. 245–248. München-Wien-Baltimore: Urban & Schwarzenberg. 1983.

    Google Scholar 

  61. Pieters, G. F. F., Smals, A. G. H., Goverde, H. J. M., Pesman, G. J., Meyer, E., Kloppenborg, P. W. C., Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushings's disease. J. Clin. Endocrinol. Metab.55 (1982), 1188–1197.

    PubMed  Google Scholar 

  62. Rabello, M. M., Snyder, P. J., Utiger, R. D., Effects on the pituitary-thyroid axis and prolactin secretion of single and repetitive oral doses of thyrotropin-releasing hormone (TRH). J. Clin. Endocrinol. Metab.39 (1974), 571–578.

    PubMed  Google Scholar 

  63. Refetoff, S., Fang, V. S., Rapoport, B., Friesen, H. G., Interrelationships in the regulation of TSH and prolactin secretion in man: Effects of L-Dopa, TRH and thyroid hormone in various combinations. J. Clin. Endocrinol. Metab.38 (1974), 450–457.

    PubMed  Google Scholar 

  64. Roti, E., Gnudi, A., Robuschi, G., Emanuele, R., Benassi, L. J., Braverman, L. E., Response of growth hormone to thyrotropinreleasing hormone during fetal life. J. Clin. Endocrinol. Metab.54 (1982), 1255–1257.

    PubMed  Google Scholar 

  65. Sack, J., Fisher, D. A., Grajwer, L. A., Lam, R. W., Wang, C. C., The response of newborn sheep to TRH with and without somatostatin. Endocrinology100 (1977), 1533–1538.

    PubMed  Google Scholar 

  66. Scanlon, M. F., Weightman, D. R., Shale, D. J., More, B., Heath, M., Snow, M. H., Lewis, M., Hall, R., Dopamine is a physiological regulator of thyrotrophin (TSH) secretion in normal man. Clin. Endocrinol.10 (1979), 7–15.

    Google Scholar 

  67. Scanlon, M. F., Wechman, A. D., Lewis, M., Pourmand, M., Rodriguez-Arnao, W. D., Weightman, D. R., Hall, R., Dopaminergic modulation of circadian thyrotrophin rhythms and thyroid hormone levels in euthyroid subjects. J. Clin. Endocrinol. Metab.51 (1980), 1251–1256.

    PubMed  Google Scholar 

  68. Scanlon, M. F., Rodriguez-Arnao, M. D., McGregor, A. M., Weightman, D., Lewis, M., Cook, D. B., Gomez-Pan, A., Hall, R., Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function. Clinical Endocrinology14 (1981), 133–143.

    PubMed  Google Scholar 

  69. Scriba, P. C., Erhardt, F., Heinze, H. G., Horn, K., Marschner, I., Pickardt, C. R., Anterior pituitary and TSH. In: Regulation of Thyroid Function (Klein, E., Reinwein, D., eds.), pp. 35–46. Stuttgart-New York: Schattauer. 1976.

    Google Scholar 

  70. Scriba, P. C., Bauer, M., Emmert, D., Fateh-Moghadam, A., Hofmann, G. G., Horn, K., Pickardt, C. R., Effects of obesity, total fasting and re-alimentation on L-thyroxine (T4),3,5,3′-L-triiodothyronine (T 3, 3,3′,5′-L-triiodothyronine (rT3), thyroxine binding globulin (TBG), cortisol, thyrotrophin, cortisol binding globulin (CBG), transferrin, α 2-haptoglobin and complement C′3 in serum. Acta Endocrinol. (Kbh)91 (1979), 629–643.

    Google Scholar 

  71. Shambaugh III G. E., Wilber, J. F., Montoya, E., Ruder, H., Blonsky, E. R., Thyrotropin-releasing hormone (TRH): Measurements in human spinal fluid. J. Clin. Endocrinol. Metab.41 (1975), 131–134.

    PubMed  Google Scholar 

  72. Snyder, P. J., Jacobs, L. S., Utiger, R. D., Daughaday, W. H., Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. J. Clin. Invest.52 (1973), 2324–2329.

    PubMed  Google Scholar 

  73. Sowers, J. R., Carlson, H. E., Brautbar, N., Hershman, J. M., Effect of dexamethasone on prolactin and TSH responses to TRH and metoclopramide in man. J. Clin. Endocrinol. Metab.44 (1977), 237–241.

    PubMed  Google Scholar 

  74. Sowers, J. R., Catania, R. A., Hershman, J. M., Evidence for dopaminergic control of circadian variations in thyrotropin secretion. J. Clin. Endocrinol. Metab.54 (1982), 673–675.

    PubMed  Google Scholar 

  75. Staub, J. J., Girard, J., Mueller-Brand, J., Noelpp, B., Werner-Zodrow, I., Baur, U., Heitz, Ph., Gemsenjaeger, E., Blunting of TSH response after repeated oral administration of TRH in normal and hypothyroid subjects. J. Clin. Endocrinol. Metab.46 (1978), 260–266.

    PubMed  Google Scholar 

  76. Szabo, M., Kovathana, N., Gordon, K., Frohman, L. A., Effect of passive immunization with an antiserum to thyrotropin (TSH)-releasing hormone on plasma TSH levels in thyroidectomized rats. Endocrinology102 (1978), 799–805.

    PubMed  Google Scholar 

  77. Tashjian, A. H., Barowksy, N. J., Jensen, D. K., Thyrotropin releasing hormone: Direct evidence for stimulation of prolactin production by pituitary cells in culture. Biochem. Biophys. Res. Comm.43 (1971), 516.

    PubMed  Google Scholar 

  78. Urman, S., Critchlow, V., Long term elevations in plasma thyrotropin but not growth hormone, concentrations associated with lesion-induced depletion of median eminence somatostatin. Endocrinology112 (1983), 659–644.

    PubMed  Google Scholar 

  79. Vale, W., Rivier, C., Brazeau, P., Guillemin, R., Effects of somatostatin on the secretion of thyrotropin and prolactin. Endocrinology95 (1974), 968–983.

    PubMed  Google Scholar 

  80. Wartofsky, L., Burman, K. D., Alterations in thyroid function in patients with systemic illness: The “euthyroid sick syndrome”. Endocrine Reviews3 (1982), 164–217.

    PubMed  Google Scholar 

  81. Wenzel, K. W., Döring, J., Lack of influence of the antidopaminergic drug domperidone on basal and TRH-stimulated TSH-serum levels after oral administration. Acta Endocrinol. (Kbh)101 (1982), 550–554.

    Google Scholar 

  82. von Werder, K., Wachstumshormone und Prolaktin. Urban & Schwarzenberg. 1975.

  83. von Werder, K., Fahlbusch, R., Gay, R., Pickardt, C. R., Schultz, B., Stimulation der Wachstumshormon- und Prolaktin-Sekretion durch TRH bei Akromegalie. Klin. Wschr.54 (1976), 335.

    PubMed  Google Scholar 

  84. Wilber, J. F., Utiger, R. D., The effect of glucocorticoids on thyrotropin secretion. J. Clin. Invest.48 (1969), 2096–2103.

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. C. R. Pickardt

    Present address: Medizinische Klinik Innenstadt der Universität München, Germany

Authors and Affiliations

  1. Klinik für Innere Medizin der Medizinischen Hochschule Lübeck, Germany

    P. C. Scriba

Authors
  1. C. R. Pickardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. C. Scriba
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pickardt, C.R., Scriba, P.C. TRH: Pathophysiologic and clinical implications. Acta neurochir 75, 43–48 (1985). https://doi.org/10.1007/BF01406322

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01406322

Keywords

Search

Navigation